Bruce Krattenmaker has deep experience leading global regulatory and clinical affairs for start-up and large medical device companies. Bruce has a legacy of new and creative approaches to gaining swift approvals for medical device technology. Prior to joining Alucent Biomedical, he was Vice President of Global Regulatory Affairs for Allergan where he led teams focused on the company’s $3 billion medical device franchise. He also served at Johnson & Johnson as Vice President of Regulatory Affairs, Quality Assurance and Clinical Programs. Bruce’s career also includes executive roles at ev3 (now Medtronic), Biocompatibles Cardiovascular, Valigen, Boston Scientific Corporation; and C.R. Bard. Krattenmaker received a Bachelor of Science in Biology and Master of Science in microbiology and biochemistry from Northern Illinois University
